ZYBT
What one share of Zhengye Biotechnology Holding Limited holds
Pharmaceutical Preparations
Our mission is to become a world-leading manufacturer of veterinary vaccines and to provide reliable veterinary vaccines to the world.
Zhengye Biotechnology Holding Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.34 |
|---|---|
| Profit | −$0.21 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.04 |
| Cash and investments | $0.15 |
| Debt | $0.23 |
| Book value | $0.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $0.85 | $0.15 | $0.09 | −$0.03 | — | $1.13 |
| 2023 | $0.66 | $0.10 | $0.02 | $0.13 | — | $0.84 |
| 2024 | $0.57 | $0.03 | $0.04 | $0.08 | — | $0.85 |
| 2025 | $0.34 | −$0.21 | $0.00 | $0.04 | — | $0.75 |